A carregar...
Therapeutic Advances in Functional Gastrointestinal Disease: Irritable Bowel Syndrome
Reported prevalence rates of irritable bowel syndrome (IBS) are between 8% to 20% in the US general population with an average medical expenditure of US$1.35 billion direct and US$205 million indirect costs. Current pathophysiologic theories are based on abnormalities of both the brain and gut, thus...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2779541/ https://ncbi.nlm.nih.gov/pubmed/19936327 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X08103656 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|